Motivation
The Pfizer mRNA “vaccine” trial 2-month data report “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine”, claimed 95% EFFICACY on the basis of RRR (relative risk reduction) in only 170 trial participants out of the total of 43,448 who received injections. This deep dive investigative article finds serious protocol violations in those crucial 170 participants, i.e. invalidating the 95% EFFICACY claim.
Author
Jeyanthi Kunadhasan
Submitted By
Dr Herman Edeling
Supported By
Dr Stephen Schmidt
Type of Article
News, The Spectator Australia